when compared with bare-metal stents (BMSs), in patients undergoing percutaneous coronary intervention. Use of these stents rapidly became widespread in clinical practice. However, reports of ...

Clinical trials investigating the benefits of DES over bare-metal stents (BMS), however, have been insufficiently powered to generate useful data on rates of mortality, myocardial infarction (MI ...

2012;4(1):1557-1564. Although drug-eluting stents (DES) are more effective than bare-metal stent (BMS) in reducing restenosis rate, there is the need for a prolonged dual antiplatelet therapy.

Drug-eluting stents reduce the occurrence of in-stent restenosis and the need for subsequent target vessel revascularization when compared with bare-metal stents. However, drug-eluting stents may ...

Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD.

As per the new prices notified by the NPPA, a bare metal stent (BMS) would now cost Rs 8,261, while the drug eluting stent (DES) will cost Rs 30,080 from April 1. A coronary stent is a tube-shaped ...

The Department has informed the Panel that the ceiling prices for coronary stents currently stand at Rs. 10,509.79 for bare metal stents (BMS) and Rs. 38,267.18 for drug eluting stents (DES), ...